108
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

, , , , , , , , & show all
Pages 387-395 | Published online: 07 Sep 2017

References

  • WierdaWGKeatingMJO’BrienSChronic lymphocytic leukemiaDeVitaVTHellmanSRosenbergSACancer Principles & Practice of Oncology8th edPhiladelphia, PALippincott Williams & Wilkins200922782292
  • HarrisLJaffeESDieboldJWorld Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997J Clin Oncol199917123835384910577857
  • ByrdJCJonesJJWoyachJAJohnsonAJFlynnJMEntering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinicianJ Clin Oncol201432273039304725049322
  • SeungAHStandard of care and novel treatments for chronic lymphocytic leukemiaAm J Health Syst Pharm201067211813182420966144
  • MandrikOCorro RamosIZalis’kaOGaisenkoASeverensJLCost for treatment of chronic lymphocytic leukemia in specialized institutions of UkraineValue in Health Regional Issues201322205209
  • VasylyevALoginovAMolostvovaVPrevalence and cumulative 5-year incidence of chronic lymphocytic leukemia in the adult population in the Russian Federation and Ukraine: data from the LEUKOSPECT studyHematology2017221162427356961
  • BlankartCRKochTLinderRVerheyenFSchreyöggJStargardtTCost of illness and economic burden of chronic lymphocytic leukemiaOrphanet J Rare Dis201383223425552
  • KolbinASVilumIABalykina YuEProskurinMAФармакоэкономический анализ применения ибрутиниба в первой линии терапии хронического лимфолейкоза у пациентов с делецией 17р. [Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion]Good Clinical Practice201513243 Russian
  • StephensJMGramegnaPLaskinBBottemanMFPashosCLChronic lymphocytic leukemia: economic burden and quality of life: literature reviewAm J Ther200512546046616148431
  • LafeuilleMHVekemanFWangSTKerriganMMendittoLDuhMSLifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemiaLeuk Lymphoma20125361146115422111902
  • Holtzer-GoorKMBouwmans-FrijtersCASchaafsmaMRUyl-de GrootCAA Cost of Illness and Quality of Life Study in Patients with B-cell Chronic Lymphocytic Leukemia (CLL) in the NetherlandsRotterdam, the NetherlandsErasmus University Rotterdam2011
  • VarkerHSongXMeyerNGregorySAPinilla-IbarzJRamseySDTreatment patterns, mortality, and costs of care in unfit patients (pts) with relapsed chronic lymphocytic leukemia (CLL)J Clin Oncol2014325 Suppl7105